SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-053237
Filing Date
2021-04-21
Accepted
2021-04-21 17:16:57
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2113689d6_4.html 4  
1 FORM 4 tm2113689d6_4.xml 4 12643
  Complete submission text file 0001104659-21-053237.txt   14203
Mailing Address C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
SQUINTO STEPHEN P (Reporting) CIK: 0001231954 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 21842476

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations